Fig. 1From: Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic reviewPreferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagramBack to article page